Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened É Amanhã! Convite Lundbeck Webinar Internacional Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
User created User created Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Apoio à saúde mental em tempos de crise Анонимен
Newsletter opened Opened Apoio à saúde mental em tempos de crise Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened É Amanhã! Convite Lundbeck Webinar Internacional Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
User created User created Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Apoio à saúde mental em tempos de crise Анонимен
Newsletter opened Opened Apoio à saúde mental em tempos de crise Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Анонимен
Newsletter opened Opened Анонимен